<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Change in bone mineral density for females using GnRH agonists</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Change in bone mineral density for females using GnRH agonists</h1>
<div class="graphic"><div class="figure"><div class="ttl">Change in bone mineral density for females using GnRH agonists</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Effects of GnRH agonist on bone density in females with endometriosis and pelvic pain. Females with endometriosis and pelvic pain were treated with the GnRH agonist leuprolide depot for 52 weeks. Group A received GnRH agonist plus placebo pills. Group B received GnRH agonist plus norethindrone acetate 5 mg daily. Group C received GnRH agonist and norethindrone acetate 5 mg and conjugated equine estrogens 0.625 mg daily, and group D received GnRH agonist and norethindrone acetate 5 mg and conjugated equine estrogens 1.25 mg daily. No significant bone density loss occurred in the groups which received the GnRH agonist plus low dose steroid add-back.</div><div class="graphic_reference">Reproduced with permission from: Hornstein MD, Surrey ES, Weinberg GW, et al. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol 1998; 91:16-24.</div><div id="graphicVersion">Graphic 53673 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
